Label Change for Viagra, Cialis, Levitra

The FDA has approved updated labeling for the erectile dysfunction drugs tadalafil, sildenafil, and Levitra.
The variety reflects a size amount of postmarketing reports of sudden sense impression loss attributed to NAION (nonarteritic ischemic optic neuropathy) , a stipulation in which line of descent flow is blocked to the optic face, states an FDA news expiry.
Tens of millions of men worldwide have used the drugs.
The reported imagery problems have been extremely rare.
This is a part of article Label Change for Viagra, Cialis, Levitra Taken from "Sildenafil Citrate Tablet" Information Blog